Cochlear Limited (OC5.F)
Frankfurt · EUR · Healthcare · Medical Devices
€86.64 (-1.11%) as of
Key statistics
- Market cap
- 5.67B
- P/E (TTM)
- 66.14
- EPS (TTM)
- 1.31
- Dividend yield
- 1.77%
- 52-week range
- 55.17 – 165.66
- Beta
- 0.24
- Revenue (TTM)
- 2.35B
- Profit margin
- 6.27%
- Volume
- 150.00
About Cochlear Limited
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Sydney, NSW, Australia
- Employees
- 5,400
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.